Breaking News

Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd.

Petition for certiorari denied on October 3, 2022
Docket No. Op. Below Argument Opinion Vote Author Term
21-1283 2nd Cir. N/A N/A N/A N/A OT 2022

Issues: (1) Whether, despite the Supreme Court’s “well established” interpretation of the Sherman Act, U.S. courts may reinterpret the same text of that act case by case using a discretionary 10-factor balancing test under the doctrine of prescriptive comity; and (2) whether a court interpreting the meaning of foreign law under Federal Rule of Civil Procedure 44.1 is limited to the “face” of written legal materials, as the decision below held, or may also consider evidence as to how foreign law is implemented and enforced that would be relevant to the interpretive inquiry in the foreign legal system.

DateProceedings and Orders (key to color coding)
Dec 13 2021Application (21A227) to extend the time to file a petition for a writ of certiorari from January 19, 2022 to March 20, 2022, submitted to Justice Sotomayor.
Dec 16 2021Application (21A227) granted by Justice Sotomayor extending the time to file until March 21, 2022.
Mar 21 2022Petition for a writ of certiorari filed. (Response due April 22, 2022)
Apr 11 2022Brief amici curiae of Professors William S. Dodge and Paul B. Stephan filed.
Apr 12 2022Motion to extend the time to file a response from April 22, 2022 to June 21, 2022, submitted to The Clerk.
Apr 13 2022Motion to extend the time to file a response is granted and the time is extended to and including June 21, 2022.
Apr 22 2022Brief amicus curiae of Chamber of Commerce of the United States filed.
Jun 21 2022Brief of respondents Hebei Welcome Pharmaceutical Co. Ltd., et al. in opposition filed.
Jul 06 2022DISTRIBUTED for Conference of 9/28/2022.
Jul 06 2022Reply of petitioners Animal Science Products Inc., et al. filed. (Distributed)
Oct 03 2022Petition DENIED.